"Ann Intern Med"[journal] 检索结果

1581. Summaries for patients. Prevention of repeated episodes of kidney stones in adults: a clinical practice guideline from the American College of Physicians.

来源: Ann Intern Med. 2014年161卷9期I-24页

1582. Electronic health records.

作者: John W Beasley.;Christine A Sinsky.
来源: Ann Intern Med. 2014年161卷9期680页

1583. Electronic health records.

作者: Alan W Feld.
来源: Ann Intern Med. 2014年161卷9期679-80页

1584. Electronic health records.

作者: Michael E Miller.
来源: Ann Intern Med. 2014年161卷9期679页

1585. Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy.

作者: Tetsuro Tsujimoto.;Ritsuko Yamamoto-Honda.
来源: Ann Intern Med. 2014年161卷9期678-9页

1586. Primary nonadherence with prescribed medication.

作者: Christopher Moriates.;Neel Shah.;Vineet Arora.
来源: Ann Intern Med. 2014年161卷9期678页

1587. The forever war.

作者: Ross M Boyce.
来源: Ann Intern Med. 2014年161卷9期676-7页

1588. Painful diabetic neuropathy: many similarly effective therapies with widely dissimilar costs.

作者: Brian C Callaghan.;Eva L Feldman.
来源: Ann Intern Med. 2014年161卷9期674-5页

1589. Toward tuberculosis elimination in low-incidence countries: reflections from a global consultation.

作者: Knut Lönnroth.;Giovanni Battista Migliori.;Mario Raviglione.
来源: Ann Intern Med. 2014年161卷9期670-1页

1590. Aligning expansion of graduate medical education with recent recommendations for reform.

作者: Richard E Rieselbach.;Paul H Rockey.;Robert L Phillips.;Kathleen Klink.;Malcolm Cox.
来源: Ann Intern Med. 2014年161卷9期668-9页

1591. Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians.

作者: Amir Qaseem.;Paul Dallas.;Mary Ann Forciea.;Melissa Starkey.;Thomas D Denberg.; .
来源: Ann Intern Med. 2014年161卷9期659-67页

The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the comparative effectiveness and safety of preventive dietary and pharmacologic management of recurrent nephrolithiasis in adults.

1592. Association between atrial fibrillation and silent cerebral infarctions: a systematic review and meta-analysis.

作者: Shadi Kalantarian.;Hakan Ay.;Randy L Gollub.;Hang Lee.;Kallirroi Retzepi.;Moussa Mansour.;Jeremy N Ruskin.
来源: Ann Intern Med. 2014年161卷9期650-8页

Atrial fibrillation (AF) is a common cause of stroke. Silent cerebral infarctions (SCIs) are known to occur in the presence and absence of AF, but the association between these disorders has not been well-defined.

1593. Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis.

作者: Marcio L Griebeler.;Oscar L Morey-Vargas.;Juan P Brito.;Apostolos Tsapas.;Zhen Wang.;Barbara G Carranza Leon.;Olivia J Phung.;Victor M Montori.;M Hassan Murad.
来源: Ann Intern Med. 2014年161卷9期639-49页

Multiple treatments for painful diabetic peripheral neuropathy are available.

1594. Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study.

作者: Anu Osinusi.;Anita Kohli.;Miriam M Marti.;Amy Nelson.;Xiaozhen Zhang.;Eric G Meissner.;Rachel Silk.;Kerry Townsend.;Phillip S Pang.;G Mani Subramanian.;John G McHutchison.;Anthony S Fauci.;Henry Masur.;Shyam Kottilil.
来源: Ann Intern Med. 2014年161卷9期634-8页

The interferon (IFN)-free regimen of sofosbuvir and ribavirin for 24 weeks was recently approved to treat chronic hepatitis C virus (HCV) genotype 1 (GT-1) infection for patients ineligible for IFN. However, sofosbuvir plus ribavirin therapy is associated with relapse in 15% to 30% of patients with HCV GT-1. Neither the mechanism of relapse nor the optimal re-treatment strategy for these patients is defined.

1595. Cost-effectiveness of allopurinol and febuxostat for the management of gout.

作者: Eric Jutkowitz.;Hyon K Choi.;Laura T Pizzi.;Karen M Kuntz.
来源: Ann Intern Med. 2014年161卷9期617-26页

Gout is the most common inflammatory arthritis in the United States.

1596. Screening and treatment of thyroid dysfunction: an evidence review for the U.S. Preventive Services Task Force.

作者: J Bruin Rugge.;Christina Bougatsos.;Roger Chou.
来源: Ann Intern Med. 2015年162卷1期35-45页

In 2004, the U.S. Preventive Services Task Force found insufficient evidence to recommend thyroid screening.

1597. Effect of Ebola progression on transmission and control in Liberia.

作者: Dan Yamin.;Shai Gertler.;Martial L Ndeffo-Mbah.;Laura A Skrip.;Mosoka Fallah.;Tolbert G Nyenswah.;Frederick L Altice.;Alison P Galvani.
来源: Ann Intern Med. 2015年162卷1期11-7页

The Ebola outbreak that is sweeping across West Africa is the largest, most volatile, and deadliest Ebola epidemic ever recorded. Liberia is the most profoundly affected country, with more than 3500 infections and 2000 deaths recorded in the past 3 months.

1598. Weekly dalbavancin was noninferior to daily vancomycin for acute bacterial skin infection in adults.

作者: Fainareti N Zervou.;Ioannis M Zacharioudakis.;Eleftherios Mylonakis.
来源: Ann Intern Med. 2014年161卷8期JC9页

1599. Pooled RCTs: atorvastatin did not increase renal-related serious adverse events.

作者: William Herrington.;Richard Haynes.
来源: Ann Intern Med. 2014年161卷8期JC8页

1600. Review: In alcohol use disorders, oral naltrexone, 50 mg/d, or acamprosate reduces return to drinking.

作者: Kevin L Kraemer.
来源: Ann Intern Med. 2014年161卷8期JC7页

结果排序

文献格式

出版时间

出版类型

出版语言